Text Size

Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B

This study is currently recruiting participants.
Verified September 2012 by Peking University First Hospital
Sponsor:
Collaborator:
Beijing Municipal Science & Technology Commission
Information provided by (Responsible Party):
hong zhao, Peking University First Hospital
ClinicalTrials.gov Identifier:
NCT01679769
First received: September 1, 2012
Last updated: NA
Last verified: September 2012
History: No changes posted
  Purpose

The aim of our study is to evaluate liver fibrosis using biochemical markers, FibroScan, and radiology methods in patients with chronic hepatitis B in mainland China.


Condition
Chronic Hepatitis B

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Peking University First Hospital:

Estimated Enrollment: 720
Study Start Date: May 2012
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with chronic hepatitis B or compensated cirrhosis due to chronic HBV infection

Criteria

Inclusion Criteria:

  • clinical diagnosis of chronic hepatitis B or compensated cirrhosis due to chronic HBV infection
  • agree to have liver biopsy

Exclusion Criteria:

  • clinical diagnosis of decompensated cirrhosis due to HBV or inactive carrier
  • liver diseases due to other origin
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01679769

Contacts
Contact: hong zhao 13810765943 minmin2001@gmail.com

Locations
China, Bei Jing
Peking University First Hospital Recruiting
Bei Jing, Bei Jing, China, 100034
Contact: Ying Wang     86-10-66551211        
Sponsors and Collaborators
Peking University First Hospital
Beijing Municipal Science & Technology Commission
  More Information

No publications provided

Responsible Party: hong zhao, associate professor, Peking University First Hospital
ClinicalTrials.gov Identifier: NCT01679769     History of Changes
Other Study ID Numbers: 2012-455, 81170386
Study First Received: September 1, 2012
Last Updated: September 1, 2012
Health Authority: China: Ethics Committee
China: Ministry of Health

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis, Chronic
Hepatitis B, Chronic
Liver Diseases
Digestive System Diseases
 Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Hepadnaviridae Infections
DNA Virus Infections

ClinicalTrials.gov processed this record on May 22, 2013